These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 30134846

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK.
    Linde C, Qin L, Bakhai A, Furuland H, Evans M, Ayoubkhani D, Palaka E, Bennett H, McEwan P.
    ESC Heart Fail; 2019 Apr; 6(2):280-290. PubMed ID: 30629342
    [Abstract] [Full Text] [Related]

  • 3. Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom.
    Linde C, Bakhai A, Furuland H, Evans M, McEwan P, Ayoubkhani D, Qin L.
    J Am Heart Assoc; 2019 Nov 19; 8(22):e012655. PubMed ID: 31711387
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. A cost-effectiveness analysis of patiromer in the UK: evaluation of hyperkalaemia treatment and lifelong RAASi maintenance in chronic kidney disease patients with and without heart failure.
    Ward T, Lewis RD, Brown T, Baxter G, de Arellano AR.
    BMC Nephrol; 2023 Mar 09; 24(1):47. PubMed ID: 36890464
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Associations between serum potassium and adverse clinical outcomes: A systematic literature review.
    Palaka E, Grandy S, Darlington O, McEwan P, van Doornewaard A.
    Int J Clin Pract; 2020 Jan 09; 74(1):e13421. PubMed ID: 31532067
    [Abstract] [Full Text] [Related]

  • 10. Serum potassium abnormalities, renin-angiotensin-aldosterone system inhibitor discontinuation, and clinical outcomes in patients with chronic cardiovascular, metabolic, and renal conditions: A population-based analysis.
    Jiménez-Marrero S, Cainzos-Achirica M, Monterde D, Vela E, Enjuanes C, Yun S, Garay A, Moliner P, Corbella M, Jovells-Vaqué S, Alcoberro L, Pons-Riverola A, Ramos-Polo R, Morillas H, Gómez-Hospital JA, Comin-Colet J.
    Eur J Intern Med; 2024 Jul 09; 125():89-97. PubMed ID: 38548513
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association of Changes in Creatinine and Potassium Levels After Initiation of Renin Angiotensin Aldosterone System Inhibitors With Emergency Department Visits, Hospitalizations, and Mortality in Individuals With Chronic Kidney Disease.
    Garlo KG, Bates DW, Seger DL, Fiskio JM, Charytan DM.
    JAMA Netw Open; 2018 Nov 02; 1(7):e183874. PubMed ID: 30646338
    [Abstract] [Full Text] [Related]

  • 13. Maintaining Renin-Angiotensin-Aldosterone System Inhibitor Treatment with Patiromer in Hyperkalaemic Chronic Kidney Disease Patients: Comparison of a Propensity-Matched Real-World Population with AMETHYST-DN.
    Chinnadurai R, Rengarajan S, Budden JJ, Quinn CM, Kalra PA.
    Am J Nephrol; 2023 Nov 02; 54(9-10):408-415. PubMed ID: 37725919
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum Potassium, End-Stage Renal Disease and Mortality in Chronic Kidney Disease.
    Nakhoul GN, Huang H, Arrigain S, Jolly SE, Schold JD, Nally JV, Navaneethan SD.
    Am J Nephrol; 2015 Nov 02; 41(6):456-63. PubMed ID: 26228532
    [Abstract] [Full Text] [Related]

  • 17. Clinical and Economic Impact of Hyperkalemia in Patients with Chronic Kidney Disease and Heart Failure.
    Polson M, Lord TC, Kangethe A, Speicher L, Farnum C, Brenner M, Oestreicher N, Alvarez P.
    J Manag Care Spec Pharm; 2017 Apr 02; 23(4-a Suppl):S2-S9. PubMed ID: 28436256
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Association between hyperkalemia, RAASi non-adherence and outcomes in chronic kidney disease.
    Santoro A, Perrone V, Giacomini E, Sangiorgi D, Alessandrini D, Degli Esposti L.
    J Nephrol; 2022 Mar 02; 35(2):463-472. PubMed ID: 34115311
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.